What FDA Regulatory Documents Reveal About Batch Release Limits and Reagent Suitability
Compare FDA statements on sterility-test limits and endotoxin assay suitability, with a focus on the separate claims each record supports.
Read articleArticle category
Laboratory reports, sample identity and product documentation.

Compare FDA statements on sterility-test limits and endotoxin assay suitability, with a focus on the separate claims each record supports.
Read articleRead peptide LC-MS identity findings in context, with original evidence separating identity confirmation from purity, sequence and quantity claims.
Read articleAn in vitro bivalirudin NMR study illustrates why peptide characterization claims should stay tied to the methods and variants actually examined.
Read articleRead peptide COAs by matching sample identifiers, analytical purposes and supporting data, with context from peptide research and official guidance.
Read articleUnderstand how researchers use ICH Q2(R2) guidelines and in vitro testing to evaluate analytical method validation, verify peptide identity, and assess limits.
Read articleA review of how peptide purity is measured in laboratories, explaining why LC-UV area normalization and ICH Q2(R2) guidelines define method-dependent limits.
Read articleLearn how to read a research peptide certificate of analysis critically. Trace lot numbers, HPLC purity methods, and mass spectrometry data to verify results.
Read articleA clearer starting point
Find a research path, read a guide or take a closer look at a laboratory report.